BRPI0015061B1 - comprimido revestido tendo alta dosagem de cloridrato de sevelamer - Google Patents
comprimido revestido tendo alta dosagem de cloridrato de sevelamer Download PDFInfo
- Publication number
- BRPI0015061B1 BRPI0015061B1 BRPI0015061A BR0015061A BRPI0015061B1 BR PI0015061 B1 BRPI0015061 B1 BR PI0015061B1 BR PI0015061 A BRPI0015061 A BR PI0015061A BR 0015061 A BR0015061 A BR 0015061A BR PI0015061 B1 BRPI0015061 B1 BR PI0015061B1
- Authority
- BR
- Brazil
- Prior art keywords
- tablet
- aliphatic amine
- coating
- amine polymer
- core
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Abstract
Description
Claims (5)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16025899P | 1999-10-19 | 1999-10-19 | |
US17422700P | 2000-01-03 | 2000-01-03 | |
PCT/US2000/028548 WO2001028527A2 (en) | 1999-10-19 | 2000-10-13 | Direct compression polymer tablet core |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0015061A BR0015061A (pt) | 2002-07-23 |
BRPI0015061B1 true BRPI0015061B1 (pt) | 2016-03-22 |
BRPI0015061B8 BRPI0015061B8 (pt) | 2021-05-25 |
Family
ID=26856737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0015061A BRPI0015061B8 (pt) | 1999-10-19 | 2000-10-13 | comprimido revestido tendo alta dosagem de cloridrato de sevelamer |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1239837B1 (pt) |
JP (4) | JP4942271B2 (pt) |
KR (1) | KR100794427B1 (pt) |
CN (1) | CN1202812C (pt) |
AR (1) | AR026067A1 (pt) |
AT (1) | ATE286386T1 (pt) |
AU (1) | AU778262B2 (pt) |
BG (1) | BG106626A (pt) |
BR (1) | BRPI0015061B8 (pt) |
CA (1) | CA2387915C (pt) |
CZ (1) | CZ20021344A3 (pt) |
DE (1) | DE60017285T2 (pt) |
EA (1) | EA200200387A1 (pt) |
EE (1) | EE200200209A (pt) |
ES (1) | ES2235969T3 (pt) |
HK (1) | HK1049451B (pt) |
HU (1) | HUP0203334A2 (pt) |
IL (1) | IL149146A0 (pt) |
IS (1) | IS6343A (pt) |
MX (1) | MXPA02003684A (pt) |
MY (1) | MY125495A (pt) |
NO (1) | NO20021827L (pt) |
NZ (1) | NZ518334A (pt) |
PL (1) | PL364888A1 (pt) |
PT (1) | PT1239837E (pt) |
SK (1) | SK5412002A3 (pt) |
TR (1) | TR200201087T2 (pt) |
TW (1) | TWI225413B (pt) |
WO (1) | WO2001028527A2 (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU778262B2 (en) * | 1999-10-19 | 2004-11-25 | Genzyme Corporation | Direct compression polymer tablet core |
US7608674B2 (en) | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
US7335795B2 (en) | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
US7767768B2 (en) | 2003-11-03 | 2010-08-03 | Ilypsa, Inc. | Crosslinked amine polymers |
WO2005065291A2 (en) * | 2003-12-31 | 2005-07-21 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
ES2659386T3 (es) | 2004-03-30 | 2018-03-15 | Relypsa, Inc. | Composiciones de unión a iones y su uso |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
AU2012200480B2 (en) * | 2004-11-01 | 2014-10-16 | Genzyme Corporation | "Aliphatic amine polymer salts for tableting" |
BRPI0609524A2 (pt) * | 2005-03-17 | 2011-10-18 | Amgen Inc | uso de uma quantidade terapeuticamente eficaz de um composto calcimimético |
EP1951266A2 (en) | 2005-09-02 | 2008-08-06 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
PT1924246E (pt) * | 2005-09-15 | 2016-02-10 | Genzyme Corp | Formulação sachê para polímeros com funcionalidade amina |
KR20090051240A (ko) * | 2006-09-01 | 2009-05-21 | 유에스브이 리미티드 | 세벨라머 염산염의 제조방법 및 그의 제형 |
JP2010504975A (ja) | 2006-09-29 | 2010-02-18 | ゲンズイメ コーポレーション | アミドデンドリマー組成物 |
JP2010513271A (ja) | 2006-12-14 | 2010-04-30 | ゲンズイメ コーポレーション | アミド−アミンポリマー組成物 |
WO2009034540A1 (en) * | 2007-09-11 | 2009-03-19 | Ranbaxy Laboratories Limited | Pharmaceutical composition of sevelamer |
DE102008030046A1 (de) * | 2008-06-25 | 2009-12-31 | Ratiopharm Gmbh | Kompaktiertes Polyallylamin-Polymer |
RU2011112694A (ru) | 2008-09-02 | 2012-10-10 | Юсв Лимитед (In) | Сшитые полимеры |
US20100330175A1 (en) * | 2009-06-24 | 2010-12-30 | Jobdevairakkam Christopher N | Cross-linked polyallylamine tablet core |
ES2350999B1 (es) * | 2009-06-26 | 2011-12-07 | Combino Pharm, S.L. | Nueva composición farmacéutica comprendiendo hidrocloruro de poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxi propano). |
WO2010149794A2 (en) * | 2009-06-26 | 2010-12-29 | Combino Pharm, S.L. | Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane) |
EA024699B1 (ru) * | 2009-10-22 | 2016-10-31 | Синтон Б. В. | Фармацевтическая таблетка с немедленным высвобождением, содержащая севеламера карбонат |
EP2545907A1 (en) | 2011-07-15 | 2013-01-16 | Combino Pharm, S.L. | Aqueous wet granulation process for cross-linked polyallylamine polymers |
TW201400146A (zh) * | 2012-06-05 | 2014-01-01 | Takeda Pharmaceutical | 有核錠 |
CN102908325B (zh) * | 2012-11-12 | 2014-07-30 | 南京生命能科技开发有限公司 | 一种碳酸司维拉姆药用片剂组合物及其制备方法 |
CN107412166B (zh) * | 2017-08-08 | 2020-03-24 | 同济大学 | 一种纳米复合吸附磷材料及其制备与应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2108090C1 (ru) * | 1991-07-03 | 1998-04-10 | Дзе Апджон Компани | Таблетка, содержащая гидрохлорид колестипола, и способ ее получения |
US5496545A (en) * | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
TW592727B (en) * | 1997-04-04 | 2004-06-21 | Chugai Pharmaceutical Co Ltd | Phosphate-binding polymer preparations |
JP3389493B2 (ja) * | 1997-04-04 | 2003-03-24 | 中外製薬株式会社 | リン酸結合性ポリマー製剤 |
US6083497A (en) * | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
TW568788B (en) * | 1998-10-12 | 2004-01-01 | Chugai Pharmaceutical Co Ltd | Polymer combining with phosphoric acid and preparation containing the same |
AU778262B2 (en) * | 1999-10-19 | 2004-11-25 | Genzyme Corporation | Direct compression polymer tablet core |
-
2000
- 2000-10-13 AU AU10887/01A patent/AU778262B2/en not_active Expired
- 2000-10-13 CZ CZ20021344A patent/CZ20021344A3/cs unknown
- 2000-10-13 DE DE60017285T patent/DE60017285T2/de not_active Expired - Lifetime
- 2000-10-13 KR KR1020027005018A patent/KR100794427B1/ko active IP Right Grant
- 2000-10-13 PT PT00972191T patent/PT1239837E/pt unknown
- 2000-10-13 PL PL00364888A patent/PL364888A1/xx unknown
- 2000-10-13 JP JP2001531357A patent/JP4942271B2/ja not_active Expired - Lifetime
- 2000-10-13 ES ES00972191T patent/ES2235969T3/es not_active Expired - Lifetime
- 2000-10-13 WO PCT/US2000/028548 patent/WO2001028527A2/en active IP Right Grant
- 2000-10-13 CN CNB008146071A patent/CN1202812C/zh not_active Expired - Lifetime
- 2000-10-13 HU HU0203334A patent/HUP0203334A2/hu unknown
- 2000-10-13 EE EEP200200209A patent/EE200200209A/xx unknown
- 2000-10-13 SK SK541-2002A patent/SK5412002A3/sk unknown
- 2000-10-13 BR BRPI0015061A patent/BRPI0015061B8/pt not_active IP Right Cessation
- 2000-10-13 CA CA002387915A patent/CA2387915C/en not_active Expired - Fee Related
- 2000-10-13 TR TR2002/01087T patent/TR200201087T2/xx unknown
- 2000-10-13 EA EA200200387A patent/EA200200387A1/ru unknown
- 2000-10-13 MX MXPA02003684A patent/MXPA02003684A/es active IP Right Grant
- 2000-10-13 NZ NZ518334A patent/NZ518334A/en not_active IP Right Cessation
- 2000-10-13 EP EP00972191A patent/EP1239837B1/en not_active Expired - Lifetime
- 2000-10-13 AT AT00972191T patent/ATE286386T1/de active
- 2000-10-13 IL IL14914600A patent/IL149146A0/xx unknown
- 2000-10-17 TW TW089121646A patent/TWI225413B/zh not_active IP Right Cessation
- 2000-10-18 MY MYPI20004885A patent/MY125495A/en unknown
- 2000-10-18 AR ARP000105456A patent/AR026067A1/es unknown
-
2002
- 2002-04-15 IS IS6343A patent/IS6343A/is unknown
- 2002-04-18 NO NO20021827A patent/NO20021827L/no not_active Application Discontinuation
- 2002-04-19 BG BG106626A patent/BG106626A/bg unknown
-
2003
- 2003-03-06 HK HK03101656.0A patent/HK1049451B/zh not_active IP Right Cessation
-
2011
- 2011-12-29 JP JP2011290234A patent/JP5583110B2/ja not_active Expired - Lifetime
-
2014
- 2014-01-21 JP JP2014008451A patent/JP5903111B2/ja not_active Expired - Lifetime
-
2015
- 2015-09-03 JP JP2015173635A patent/JP2016000753A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9931358B2 (en) | Direct compression polymer tablet core | |
JP5903111B2 (ja) | 直接圧縮ポリマー錠剤コア | |
US20130315995A1 (en) | Direct compression polymer tablet core | |
PT1304104E (pt) | Comprimido compreendendo um polímero de ligação a fosfato | |
JP2004501186A (ja) | アレンドロン酸塩及び/又はその他のビスホスホン酸塩の遅延型胃内放出のための組成物及び製剤 | |
JP2012504551A (ja) | 胃保持型医薬剤形 | |
KR102276547B1 (ko) | 오메프라졸, 에스오메프라졸 또는 이의 약제학적으로 허용가능한 염을 포함하는 정제 형태의 약학 조성물 및 이의 제조방법 | |
US20100166861A1 (en) | Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone | |
CA2576135C (en) | Direct compression polymer tablet core | |
PT92682B (pt) | Processo para a preparacao de uma composicao a base de trimebutina de libertacao prolongada | |
Harsoda et al. | Formulation and Evaluation of Novel Unidirectional Release Buccal Tablet of Diclofenac Sodium | |
KR20230158919A (ko) | 레바미피드를 포함하는 경구투여용 서방성 약학 조성물 | |
Lalit et al. | Formulation Development and Evaluation of Floating Tablets of Venlafaxine Hydrochloride | |
WO2006136927A1 (en) | Extended release formulations comprising venlafaxine | |
BRPI0621323A2 (pt) | formulação farmacêutica e métodos para fabricação de polìmeros de amina alifática |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: GENZYME CORPORATION (US) Free format text: TRANSFERIDO DE: GELTEX PHARMACEUTICALS, INC. |
|
B25G | Requested change of headquarter approved |
Owner name: GENZYME CORPORATION (US) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 018080029522/SP DE 14/05/2008. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 9/20 Ipc: A61K 31/785 (2009.01), A61K 9/28 (2009.01), A61K 3 |
|
B15V | Prolongation of time limit allowed |
Free format text: DEVOLUCAO DE PRAZO CONCEDIDA - RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 19 DIAS, NOS TERMOS DO ARTIGO 221 PARAGRAFO 2O DA LPI E DA RESOLUCAO 116/04. |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/03/2016, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/10/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 13/10/2020 |